ow dose rectal diclofenac for prevention of Post-ESD Coagulation Syndrome(LOWER PECS): a randomized controlled trial - Low dose rectal diclofenac for prevention of Post-ESD Coagulation Syndrome(LOWER PECS): a randomized controlled trial

Omori Red Cross Hospital, Department of Gastroenterology0 个研究点目标入组 160 人开始时间: 2021年7月2日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) major organ failure (Liver disease; Child-Pugh classification C, Renal disease; stage 4 or higher, Heart failure; NYHA classification 3 or higher). 2) Performance Status(ECOG) 3 or 4. 3) Patients who use steroids or NSAIDs regularly. 4) Patients with Visual analog scale (VAS) >20mm, WBC > 10000, or body temperature > 37.0 at the time before ESD. 5) Patients who are contraindicant to NSAIDs use. 6) Patients who are going to have ESD or EMR for multiple lesions simultaneously. 7) The cases of intraoperative perforation. 8) The patients who are judged by attending doctors as not suitable for this trial. If systolic blood pressure is under 70 mmHg, diclofenac sodium cannot be given to the patient.

发起方

Omori Red Cross Hospital, Department of Gastroenterology